Botulinum toxin injections for the treatment of hemifacial spasm over 16 years

Journal of Clinical Neuroscience

Volumn 22, Issue 8, 2015, Pages 1319-1325

  Sorgun, Mine Hayriye ^a   Yilmaz, Rezzak ^b   Akin, Yusuf Alper ^a   Mercan, Fatma Nazli ^a   Akbostanci, Muhittin Cenk ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Botox; Botulinum toxin; Dysport; Hemifacial spasm

Indexed keywords

BOTULINUM TOXIN; ANTIPARKINSON AGENT; BOTULINUM TOXIN A;

ADULT; ARTICLE; BLURRED VISION; COMPARATIVE STUDY; CONJUNCTIVAL HYPEREMIA; CONTROLLED STUDY; DIPLOPIA; DRUG ADMINISTRATION; DRUG EFFICACY; DRUG SAFETY; DRY EYE; ECCHYMOSIS; EPISTAXIS; EYE PAIN; EYELID CLOSURE; FACE ASYMMETRY; FEMALE; HEMIFACIAL SPASM; HUMAN; INJECTION SITE ECCHYMOSIS; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALE; MUSCLE SPASM; PRESEPTAL INJECTION; PRETARSAL INJECTION; PRIORITY JOURNAL; PTOSIS; RETROSPECTIVE STUDY; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; AGED; INJECTION; MEDICINAL CHEMISTRY; MIDDLE AGED; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; BOTULINUM TOXINS, TYPE A; CHEMISTRY, PHARMACEUTICAL; FEMALE; HEMIFACIAL SPASM; HUMANS; INJECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84937525499     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2015.02.032     Document Type: Article

References (71)

1. A. Wang, and J. Jankovic Hemifacial spasm: clinical findings and treatment Muscle Nerve 21 1998 1740 1747
2. V.K. Nielsen Electrophysiology of the facial nerve in hemifacial spasm: ectopic/ephaptic excitation Muscle Nerve 8 1985 545 555
3. R.G. Auger, and J.P. Whisnant Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984 Arch Neurol 47 1990 1233 1234
4. L.D. Oliveira, F. Cardoso, and A.P. Vargas Hemifacial spasm and arterial hypertension Mov Disord 14 1999 832 835
5. N.C. Tan, L.L. Chan, and E.K. Tan Hemifacial spasm and involuntary facial movements QJM 95 2002 493 500
6. G.E. Alexander, and H. Moses 3rd. Carbamazepine for hemifacial spasm Neurology 32 1982 286 287
7. O. Daniele, G. Caravaglios, C. Marchini, and et al. Gabapentin in the treatment of hemifacial spasm Acta Neurol Scand 104 2001 110 112
8. Y. Yuan, Y. Wang, S.X. Zhang, and et al. Microvascular decompression in patients with hemifacial spasm: report of 1200 cases Chin Med J (Engl) 118 2005 833 836
9. A. Marchetti, R. Magar, L. Findley, and et al. Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study Mov Disord 20 2005 937 944
10. J.S. Elston Botulinum toxin treatment of hemifacial spasm J Neurol Neurosurg Psychiatry 49 1986 827 829
11. J.A. Mauriello Jr. Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin Neurology 35 1985 1499 1500
12. J. Jankovic, W.E. Havins, and R.B. Wilkins Blinking and blepharospasm. Mechanism, diagnosis, and management JAMA 248 1982 3160 3164
13. S. Badarny, Z. Susel, and S. Honigman Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox Isr Med Assoc J 10 2008 520 522
14. K. Kollewe, B. Mohammadi, R. Dengler, and et al. Hemifacial spasm and reinnervation synkinesias: long-term treatment with either Botox or Dysport J Neural Transm 117 2010 759 763
15. C. Colosimo, M. Chianese, M. Giovannelli, and et al. Botulinum toxin type B in blepharospasm and hemifacial spasm J Neurol Neurosurg Psychiatry 74 2003 687
16. A.R. Bentivoglio, T. Ialongo, F. Bove, and et al. Retrospective evaluation of the dose equivalence of Botox(®) and Dysport(®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story Neurol Sci 33 2012 261 267
17. P.N. Chong Botulinum toxin in the treatment of hemifacial spasm Singapore Med J 31 1990 469 471
18. M. Rudzinska, M. Wojcik, and A. Szczudlik Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy J Neural Transm 117 2010 765 772
19. C.J. Wu, J.H. Shen, Y. Chen, and et al. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm Turk Neurosurg 21 2011 625 629
20. A. Poonyathalang, P. Preechawat, and U. Jamnansiri Low-dose botulinum toxin a for treatment of blepharospasm and hemifacial spasm Jpn J Ophthalmol 49 2005 327 328
21. S. Jitpimolmard, S. Tiamkao, and M. Laopaiboon Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases J Neurol Neurosurg Psychiatry 64 1998 751 757
22. P. Van den Bergh, J. Francart, S. Mourin, and et al. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin Muscle Nerve 18 1995 720 729
23. O.H. Ababneh, A. Cetinkaya, and D.R. Kulwin Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm Clin Experiment Ophthalmol 42 2014 254 261
24. E.M. Quagliato, E.F. Carelli, and M.A. Viana Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment Clin Neuropharmacol 33 2010 27 31
25. A. Berardelli, A. Formica, B. Mercuri, and et al. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group Ital J Neurol Sci 14 1993 361 367
26. N. Poungvarin, A. Viriyavejakul, and C. Komoltri Placebo-controlled double-blind cross-over study of botulinum A toxin in hemifacial spasm Parkinsonism Relat Disord 1 1995 85 88
27. Y.C. Park, J.K. Lim, D.K. Lee, and et al. Botulinum a toxin treatment of hemifacial spasm and blepharospasm J Korean Med Sci 8 1993 334 340
28. D.M. Yoshimura, M.J. Aminoff, T.A. Tami, and et al. Treatment of hemifacial spasm with botulinum toxin Muscle Nerve 15 1992 1045 1049
29. J. Jankovic, K. Schwartz, and D.T. Donovan Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm J Neurol Neurosurg Psychiatry 53 1990 633 639
30. C. Sampaio, J.J. Ferreira, F. Simoes, and et al. DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-Dysport and Botox-assuming a ratio of 4:1 Mov Disord 12 1997 1013 1018
31. M.C. Kwan, K.F. Ko, T.P. Chan, and et al. Treatment of dystonia with botulinum A toxin: a retrospective study of 170 patients Hong Kong Med J 4 1998 279 282
32. L.B. Chang, C.P. Tsai, K.K. Liao, and et al. Use of botulinum toxin A in the treatment of hemifacial spasm and blepharospasm Zhonghua Yi Xue Za Zhi (Taipei) 62 1999 1 5
33. A. Thussu, C.R. Barman, and S. Prabhakar Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation Neurol India 47 1999 206 209
34. M. Gupta, G. Singh, and G. Khwaja Botulinum toxin in the treatment of dystonias - a hospital based study J Assoc Physicians India 51 2003 447 453
35. A.R. Bentivoglio, A. Fasano, T. Ialongo, and et al. Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm Eur J Neurol 16 2009 392 398
36. S. Cillino, G. Raimondi, N. Guepratte, and et al. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes Eye (Lond) 24 2010 600 607
37. A.R. Bentivoglio, T. Ialongo, F. Bove, and et al. Retrospective evaluation of the dose equivalence of Botox(®) and Dysport (®) in the management of blepharospasm and hemifacial spasm: a novel paradigm for a never ending story Neurol Sci 33 2012 261 267
38. J.D. Taylor, S.P. Kraft, M.S. Kazdan, and et al. Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study Can J Ophthalmol 26 1991 133 138
39. P.N. Chong, B. Ong, and R. Chan Botulinum toxin in the treatment of facial dyskinesias Ann Acad Med Singapore 20 1991 223 227
40. N. Poungvarin, and A. Viriyavejakul Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin injection J Med Assoc Thai 75 1992 199 203
41. M. Flanders, D. Chin, and D. Boghen Botulinum toxin: preferred treatment for hemifacial spasm Eur Neurol 33 1993 316 319
42. G. Defazio, G. Abbruzzese, P. Girlanda, and et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study Arch Neurol 59 2002 418 420
43. E.R. Barbosa, L.T. Takada, L.R. Goncalves, and et al. Botulinum toxin type A in the treatment of hemifacial spasm: an 11-year experience Arq Neuropsiquiatr 68 2010 502 505
44. J.R. Ainsworth, and S.P. Kraft Long-term changes in duration of relief with botulinum toxin treatment: of essential blepharospasm and hemifacial spasm Ophthalmology 102 1995 2036 2040
45. M. Snir, D. Weinberger, D. Bourla, and et al. Quantitative changes in botulinum toxin A treatment over time in patients with essential blepharospasm and idiopathic hemifacial spasm Am J Ophthalmol 136 2003 99 105
46. J.D. Rollnik, M. Matzke, K. Wohlfarth, and et al. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance - an open label study Eur Neurol 43 2000 9 12
47. H.S. Gill, and S.P. Kraft Long-term efficacy of botulinum A toxin for blepharospasm and hemifacial spasm Can J Neurol Sci 37 2010 631 636
48. B.D. Geller, M. Hallett, and J. Ravits Botulinum toxin therapy in hemifacial spasm - clinical and electrophysiologic studies Muscle Nerve 12 1989 716 722
49. G.T. Drummond, and B.J. Hinz Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time Can J Ophthalmol 36 2001 398 403
50. J.S. Elston The management of blepharospasm and hemifacial spasm J Neurol 239 1992 5 8
51. P.J. Savino, R.C. Sergott, T.M. Bosley, and et al. Hemifacial spasm treated with botulinum-A toxin injection Arch Ophthalmol 103 1985 1305 1306
52. I. Lorentz Treatment of hemifacial spasm with botulinum toxin J Clin Neurosci 2 1995 132 135
53. R.S. Chen, C.S. Lu, and C.H. Tsai Botulinum toxin A injection in the treatment of hemifacial spasm Acta Neurol Scand 94 1996 207 211
54. J.A. Mauriello Jr., T. Leone, S. Dhillon, and et al. Treatment choices of 119 patients with hemifacial spasm over 11 years Clin Neurol Neurosurg 98 1996 213 216
55. A. Suputtitada, K. Phanthumchinda, C. Locharernkul, and et al. Hemifacial spasm: results of treatment with low dose botulinum toxin injection J Med Assoc Thai 87 2004 1205 1211
56. K. Bihari Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm Curr Med Res Opin 21 2005 433 438
57. S. Setthawatcharawanich, P. Sathirapanya, K. Limapichat, and et al. Factors associated with quality of life in hemifacial spasm and blepharospasm during long-term treatment with botulinum toxin Qual Life Res 20 2011 1519 1523
58. Y.P. Xu, J. Shen, Q.B. Zhu, and et al. Efficacy of botulinum toxin A for treatment of unilateral spasms of the eyelid and its prognosis Eur Rev Med Pharmacol Sci 17 2013 2974 2979
59. P.S. Cannon, K.R. MacKenzie, A.E. Cook, and et al. Difference in response to botulinum toxin type A treatment between patients with benign essential blepharospasm and hemifacial spasm Clin Exp Ophthalmol 38 2010 688 691
60. R. Laskawi, M. Ellies, C. Drobik, and et al. Botulinum toxin treatment in patients with hemifacial spasm Eur Arch Otorhinolaryngol 251 1994 271 274
61. H. Oyama, A. Ikeda, S. Inoue, and et al. Local injection of botulinum toxin type A for hemifacial spasm Neurol Med Chir (Tokyo) 42 2002 245 248 [discussion 248-9]
62. E. Ortisi, H.W. Henderson, C. Bunce, and et al. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases Eye (Lond) 20 2006 916 922
63. C.R. Rieder, P. Schestatsky, M.P. Socal, and et al. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm Clin Neuropharmacol 30 2007 39 42
64. H. Bigalke, K. Wohlfarth, A. Irmer, and et al. Botulinum A toxin: Dysport improvement of biological availability Exp Neurol 168 2001 162 170
65. A. Berardelli, A. Carta, F. Stocchi, and et al. Botulinum-a toxin injection in patients with blepharospasm, torticollis and hemifacial spasm Ital J Neurol Sci 11 1990 589 593
66. C. Gil Polo, M.F. Rodriguez Sanz, N. Berrocal Izquierdo, and et al. Blepharospasm and hemifacial spasm: long-term treatment with botulinum toxin Neurologia 28 2013 131 136
67. H.K. Kalra, and E.H. Magoon Side-effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm Ophthalmic Surg 21 1990 335 338
68. L. Wang, X. Hu, H. Dong, and et al. Clinical features and treatment status of hemifacial spasm in China Chin Med J (Engl) 127 2014 845 849
69. E.K. Tan, S. Fook-Chong, S.Y. Lum, and et al. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30) J Neurol Sci 219 2004 151 155
70. J. Price, S. Farish, H. Taylor, and et al. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections Ophthalmology 104 1997 865 868
71. R. Cakmur, V. Ozturk, F. Uzunel, and et al. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm J Neurol 249 2002 64 68